http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101177692-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 |
| filingDate | 2006-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101177692-B1 |
| titleOfInvention | Tandem Bisheterocycle Compounds Useful as Antiviral Agents, Uses thereof, and Compositions Comprising the Compounds |
| abstract | The present invention provides small molecule compounds of the tandem bisheterocycle having the P1-P2 structure, compositions comprising the compounds as well as uses thereof, wherein each of P1 and P2 has one or two heteroatoms and an unsaturated 5-member Heterocycle ring. This compound can effectively inhibit the replication of influenza viruses, the DNA replication of hepatitis B virus (HBV), and the formation of HBsAg and HBeAg. These compounds can be used in the manufacture of medicines for viral diseases and overcome the limitations of known nucleoside drugs, including cytotoxicity, the need for other structures of drug resistance against drug resistant viral strains caused by prolonged administration. Can be. The structure of the compounds according to the invention is relatively simple and easy to prepare. |
| priorityDate | 2005-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 172.